Prevalence of Trimethoprim-Sulfamethoxazole Adverse Reaction Mislabelling in Australia. Lam L, Jiang M, Bacchi S, Kovoor J, et al. Int Arch Allergy Immunol 2023;184:1225-1229.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lam L, Jiang M, Bacchi S, Kovoor J, et al. Prevalence of Trimethoprim-Sulfamethoxazole Adverse Reaction Mislabelling in Australia. Int Arch Allergy Immunol 2023;184:1225-1229.
PMID: 37673046